Skip to main content

Single-Cell Genome Sequencing Market Will Accomplish Outstanding USD 2.49 Billion Figure By 2025

 The global Single-cellgenome sequencing market size is expected to reach USD 2.49 billion by 2025. Single-cell genome sequencing implies analyzing the sequence data with enhanced next-generation sequencing proficiency from a cell. It is a potent instrument that aims to offer intelligence and understanding of genetics by carrying the examination of genomes to the cellular stage. The single-cell genome sequencing technique has a vast effect on various fields of biology comprising cancer research, immunology microbiology, neurobiology, and tissue mosaicism.

Factors such as high cost, and analytical challenges in measurement of the single molecule of DNA may hinder the development of the market in the years to come. The Single-cell genome sequencing market is anticipated to grow at a significant CAGR of 14.6% in the upcoming period as the scope, product types and its applications are increasing across the globe.

The market may be explored by product, technology, workflow, disease area, applications, end users, and geography. Single-cell genome sequencing Market may be explored by product as Instruments, and Reagents. The “Instrument” segment dominated the Single-cell genome sequencing in 2016 and is anticipated to maintain its dominance by 2025. Growth and implementation of technically progressive solutions and instruments is anticipated to propel the development of the segment in the years to come.

Request Sample Copy of This Market Research @

https://www.millioninsights.com/industry-reports/single-cell-genome-sequencing-market/request-sample

The market may be explored by Technology as MDA, PCR, qPCR, Microarray, and NGS. The NGS segment is dominated the segment technology of the Single-cell genome sequencing in 2016. And it is anticipated to maintain its dominance by 2025. Single-cell genome sequencing Market may be explored by workflow as Sample preparation, Isolation, and Genomic analysis. Single-cell genome sequencing Market may be explored by disease as Immunology, Cancer, Prenatal diagnosis, Microbiology, Neurobiology, and Others.

The “Cancer” segment dominated the market in 2016 and anticipated to maintain its dominance by 2025. Growing occurrence of colorectal, breast cancer and prostate are poised to generate profitable development opportunities. Single-cell genome sequencing Market may be explored by applications as Differentiation/ reprogramming, Subpopulation characterization, Genomic variation, CTCs, and Others. The CTCs segment dominated the Single-cell genome sequencing in 2016 and is anticipated to maintain its dominance by 2025.

The market may be explored by end users as Biotechnology & biopharmaceutical companies, Clinics, Academic & Research Laboratories, and Others. North America accounted for the major share of the global Single-cell genome sequencing Market Size Analysis in 2016 and will continue to rule the roost in the forecast period.

Some of the key players that fuel the development of the Single-cell genome sequencing Industry includes Agilent Technologies Inc, 10X Genomics, Johnson & Johnson, DNA Electronics Ltd., Zephyrus Biosciences Inc., Thermo Fisher Scientific Inc. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

Browse Full Research Report @

https://www.millioninsights.com/industry-reports/single-cell-genome-sequencing-market

Market Segment:

Single Cell Genome Sequencing Product Type Outlook (Revenue, USD Million, 2014 - 2025)
    • Instruments
    • Reagents

Single Cell Genome Sequencing Technology Outlook (Revenue, USD Million, 2014 - 2025)
    • NGS
    • PCR
    • qPCR
    • Microarray
    • MDA

Single Cell Genome Sequencing Workflow Outlook (Revenue, USD Million, 2014 - 2025)
    • Single-cell isolation
    • Sample preparation
    • Genomic analysis

Single Cell Genome Sequencing Disease Area Outlook (Revenue, USD Million, 2014 - 2025)
    • Cancer
    • Immunology
    • Prenatal diagnosis
    • Neurobiology
    • Microbiology
    • Others

Single Cell Genome Sequencing Application Outlook (Revenue, USD Million, 2014 - 2025)
    • Circulating cells
    • Cell differentiation/reprogramming
    • Genomic variation
    • Subpopulation characterization
    • Others

Single Cell Genome Sequencing End-use Outlook (Revenue, USD Million, 2014 - 2025)
    • Academic & research laboratories
    • Biotechnology & biopharmaceutical companies
    • Clinics
    • Others

Single Cell Genome Sequencing Regional Outlook (Revenue, USD Million, 2014 - 2025)
    • North America
        • U.S.
        • Canada
    • Europe
        • Germany
        • U.K.
    • Asia Pacific
        • Japan
        • China
    • Latin America
        • Brazil
    • Middle East and Africa (MEA)
        • South Africa

Read more insights on @

https://latestmarkettrends.news.blog

 

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

 

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email: ryan@millioninsights.com

Comments

Download Free Popular Research

Global Food Grade & Pharma Grade Calcium Phosphate Market Will Generate Maximum Revenue From 2020 To 2025

  Nov 05 2020:   The global   Food Grade & Pharma Grade Calcium Phosphate market   was valued at $XX million in 2018, and Radiant Research analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Food Grade & Pharma Grade Calcium Phosphate from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Food Grade & Pharma Grade Calcium Phosphate market. To Request A Sample Copy Of This Report @:     https://www.radiantinsights.com/research/2013-2028-report-on-global-food-grade-and-pharma-grade-calcium-phosphate-market/request-sample Leading players of Food Grade & Pharma Grade Calcium Phosphate including: Innophos Prayon ICL PP Chengxing Industrial Hens Budenheim Tianjia Chem Hindus

Global IT Equipment Disposal Market Analysis, Size, Share, Growth, Trends and Forecast 2018-2028: Radiant Insights Inc

April 12, 2019:  The global IT Equipment Disposal market was valued at $XX million in 2017, and Radiant Research analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2017 and 2028. To Request A Sample Copy Of This Report @: https://www.radiantinsights.com/research/2013-2028-report-on-global-it-equipment-disposal-market/request-sample This report provides detailed historical analysis of global market for IT Equipment Disposal from 2013-2018 and provides extensive market forecasts from 2018-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the IT Equipment Disposal market. To Browse Full Research Report @: https://www.radiantinsights.com/research/2013-2028-report-on-global-it-equipment-disposal-market Leading players of IT Equipment Disposal including: Eletronic Recyclers International Sims Recycling Solutions Waste Manag

Cervical Cancer Diagnostic Market Worth About USD 12 billion By 2024

  Cervical Cancer Diagnostic Market size is anticipated to reach USD 12 billion by 2024. Cervical cancer is caused due to uncontrolled cell division of cancerous or abnormal cell growth in the cervix region. The factors that propel the growth of the cervical cancer diagnostics market include increase in aging female population, rise in the awareness programs for cervical cancer screening, high occurrence rate, and rapid adoption of technology. Moreover, increasing consciousness among the population regarding prevention, care, and treatment of cervical cancer, and availability of advanced and variety of treatment are likely to offer impetus to the market. On the other hand, there are factors that may hamper the growth of the market including lack of awareness related to cervical cancer protection, and changes in regulatory guidelines for cervical cancer screening. Cervical cancer diagnostics industry is anticipated to grow at a significant CAGR of 5.9% in the upcoming period as the sc